COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis
NCT00113308 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 2208
Last updated 2017-03-14
Summary
This study is being conducted to find out if an investigational drug called GW406381 can help people with rheumatoid arthritis.
Conditions
- Arthritis, Rheumatoid
Interventions
- DRUG
-
GW406381
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials · GlaxoSmithKline
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-06-30
- Primary Completion
- 2006-09-30
- Completion
- 2006-09-30
Countries
- United States
- Argentina
- Austria
- Belgium
- Bulgaria
- Canada
- Chile
- Costa Rica
- Denmark
- Finland
- France
- Germany
- Greece
- Hungary
- India
- Ireland
- Italy
- Latvia
- Mexico
- Netherlands
- New Zealand
- Norway
- Peru
- Philippines
- Poland
- Puerto Rico
- Romania
- Russia
- South Africa
- South Korea
- Spain
- Ukraine
- United Kingdom
Study Locations
More Related Trials
-
Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK3117391 in Subjects With Rheumatoid Arthritis
NCT02965599 ·Status: TERMINATED ·Phase: PHASE2
-
Safety and Tolerability of NNC0141-0000-0100 in Subjects With Rheumatoid Arthritis
NCT01370902 ·Status: COMPLETED ·Phase: PHASE1
-
Study of GS-0272 in Participants With Rheumatoid Arthritis
NCT06031415 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Study of GS-0151 in Participants With Rheumatoid Arthritis
NCT06902519 ·Status: RECRUITING ·Phase: PHASE1
-
Safety and Tolerability of NNC0114-0006 at Increasing Dose Levels in Subjects With Rheumatoid Arthritis
NCT01565408 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Anti-TNFa Biologics
NCT01636817 ·Status: TERMINATED ·Phase: PHASE2
-
INCB047986 in Rheumatoid Arthritis
NCT02151474 ·Status: TERMINATED ·Phase: PHASE2
-
SB-681323 In Subjects With Rheumatoid Arthritis
NCT00320450 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of R935788 Tablets to Treat Rheumatoid Arthritis (Taski-3)
NCT00665626 ·Status: COMPLETED ·Phase: PHASE2
-
Multiple Ascending Doses of Rozibafusp Alfa (AMG 570) in Adults With Rheumatoid Arthritis
NCT03156023 ·Status: COMPLETED ·Phase: PHASE1
-
Double Blind, Placebo-controlled, Study of the Safety, Tolerability and Pharmacokinetics of AIN457 in Rheumatoid Arthritis Patients
NCT00669942 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
NCT01208181 ·Status: COMPLETED ·Phase: PHASE3
-
A Multiple Dose Trial of NNC 0151-0000-0000 in Subjects With Rheumatoid Arthritis
NCT01223911 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison Of 5 CP-690,550 Doses Vs. Placebo, For The Treatment Of Rheumatoid Arthritis In Japan
NCT00687193 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase I Rheumatoid Arthritis Study in Healthy Volunteers
NCT00539760 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, and Pharmacokinetics of GS-5745 in Subjects With Rheumatoid Arthritis
NCT02176876 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate Safety, Tolerability, and Efficacy of GS-5718 in Participants With Active Rheumatoid Arthritis Who Have an Inadequate Response to Disease-modifying Antirheumatic Drug(s) (bDMARDs) Treatment
NCT05165771 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study of JNJ-40346527 in Patients With Active Rheumatoid Arthritis Despite Disease-modifying Antirheumatic Drug Therapy
NCT01597739 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study of TQH3821 Tablets in the Treatment of Treated Rheumatoid Arthritis
NCT05849727 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Evaluate the Effectiveness and Safety of SKI-O-703 in Patients Experiencing Active Rheumatoid Arthritis Despite Treatment With Conventional Therapies.
NCT04057118 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of NNC0142-0002 in Subjects With Rheumatoid Arthritis (RA)
NCT01181050 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Pharmacodynamics and Pharmacokinetics of GSK2136525 Repeat Dose in Rheumatoid Arthritis
NCT01077531 ·Status: TERMINATED ·Phase: PHASE1
-
Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
NCT03980483 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess the Safety, Pharmacokinetics, and Efficacy of KPL-404 in Participants With Rheumatoid Arthritis With Inadequate Response or Intolerance to at Least One Biologic Disease-modifying Anti-rheumatic Drug or a Janus Kinase Inhibitor
NCT05198310 ·Status: COMPLETED ·Phase: PHASE2
-
Study Of 90mg Of GW274150 In Subjects Over 50 Years, Who Have Rheumatoid Arthritis (RA)
NCT00370435 ·Status: COMPLETED ·Phase: PHASE2